7 Stocks Under $10 Streaking Higher

Pharma stocks dominate this list of stocks making sharp gains in recent sessions.

This is a development-stage biopharmaceutical company focused on developing and commercializing products to treat diseases associated with inflammation. This stock is trading up 6.4% at $2.12 in recent trading.

From a technical perspective, ANTH is bouncing sharply here, right off its 50-day moving average of $1.95 with light volume. This move is pushing the stock within range of triggering a near-term breakout trade. That trade will hit once ANTH takes out some near-term overhead resistance at $2.22 with high volume.

Traders should now look for long-biased trades in ANTH, if it can sustain a move or close over $2.22 with volume that's near or above 604,652 shares. If we get that action soon, then ANTH could easily hit its April high of $2.75 or possibly even $3 in the near future.

Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals. After the all-stock transaction closes, Zalicus will be known as Epirus and will operate under the latter company's management team led by Amit Munshi as president and CEO. Current Zalicus stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ.